Editas Medicine (EDIT) Change in Accured Expenses (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Change in Accured Expenses data on file, last reported at -$543000.0 in Q3 2025.

• Change in Accured Expenses for Q3 2025 came in at -$543000.0, down 153.5% year-over-year; the trailing twelve-month figure through Sep 2025 was $8.5 million (up 327.56% YoY), and the FY2024 annual result was $1.3 million, down 29.39% from the prior year.
• Change in Accured Expenses fell to -$543000.0 in Q3 2025 per EDIT's latest filing, from $578000.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $6.8 million in Q4 2024 and troughed at -$9.6 million in Q1 2021.
• A 5-year average of $35166.7 and a median of $531500.0 in 2022 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2021 and 2023: Change in Accured Expenses surged 1905.82% in 2021, then tumbled 153.83% in 2023.
• A 5-year view of Change in Accured Expenses shows it stood at $5.3 million in 2021, then sank by 90.8% to $485000.0 in 2022, then surged by 266.6% to $1.8 million in 2023, then soared by 282.11% to $6.8 million in 2024, then sank by 107.99% to -$543000.0 in 2025.
• Business Quant data shows EDIT's Change in Accured Expenses at -$543000.0 in Q3 2025, $578000.0 in Q2 2025, and $1.7 million in Q1 2025.